FMR CORP 13D and 13G filings for United Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 10:05 am Sale |
2024-02-08 | 13G | United Therapeutics Corporation UTHR |
FMR CORP | 2,321,039 4.939% |
-265,765 (-10.27%) |
Filing |
| 2023-02-09 12:39 pm Purchase |
2023-02-09 | 13G | United Therapeutics Corporation UTHR |
FMR CORP | 2,586,804 5.675% |
63,426 (+2.51%) |
Filing |
| 2022-02-09 10:01 am Purchase |
2022-02-08 | 13G | United Therapeutics Corporation UTHR |
FMR CORP | 2,523,378 5.602% |
200,695 (+8.64%) |
Filing |
| 2021-02-08 10:35 am Sale |
2021-02-05 | 13G | United Therapeutics Corporation UTHR |
FMR CORP | 2,322,683 5.226% |
-60,866 (-2.55%) |
Filing |